The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development
Open accessAbstract
We have isolated and sequenced a novel 11-kDa virucidal protein, named cyanovirin-N (CV-N), from cultures of the cyanobacterium (blue-green alga) Nostoc ellipsosporum. We also have produced CV-N recombinantly by expression of a corresponding DNA sequence in Escherichia coli. Low nanomolar concentrations of either natural or recombinant CV-N irreversibly inactivate diverse laboratory strains and primary isolates of human immunodeficiency virus (HIV) type 1 as well as strains of HIV type 2 and simian immunodeficiency virus. In addition, CV-N aborts cell-to-cell fusion and transmission of HIV-1 infection. Continuous, 2-day exposures of uninfected CEM-SS cells or peripheral blood lymphocytes to high concentrations (e.g., 9,000 nM) of CV-N were not lethal to these representative host cell types. The antiviral activity of CV-N is due, at least in part, to unique, high-affinity interactions of CV-N with the viral surface envelope glycoprotein gp120. The biological activity of CV-N is highly resistant to physicochemical denaturation, further enhancing its potential as an anti-HIV microbicide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Self-citationKimpton, J., & Emerman, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2232-2239.1992 · Cited by 908
Weislow, O. S., Kiser, R., Fine, D. L., Bader, J., Shoemaker, R. H., & Boyd, M. R. (1989) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.577 · Cited by 685
Self-citationBurton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
Cited by
Mechanisms of Viral Membrane Fusion and Its Inhibition
Eckert, D. M., & Kim, P. S. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.777 · Cited by 1,282
Ecology of Cyanobacteria II: Their Diversity in Space and Time
(2012) · doi:10.1007/978-94-007-3855-3 · Cited by 1,078
Suganya, T., Varman, M., Masjuki, H. H., & Renganathan, S. (2016) · Renewable and Sustainable Energy Reviews · doi:10.1016/j.rser.2015.11.026 · Cited by 793
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Microalgae in Human and Animal Nutrition
Becker, W. (2003) · Handbook of Microalgal Culture · doi:10.1002/9780470995280.ch18 · Cited by 613
Exploring the potential of microalgae for new biotechnology applications and beyond: a review
Rizwan, M., Mujtaba, G., Memon, S. A., Lee, K., & Rashid, N. (2018) · Renewable and Sustainable Energy Reviews · doi:10.1016/j.rser.2018.04.034 · Cited by 578
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Wells, J. M., & Mercenier, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1840 · Cited by 537
Search and Discovery Strategies for Biotechnology: the Paradigm Shift
Bull, A. T., Ward, A. C., & Goodfellow, M. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.3.573-606.2000 · Cited by 477
Biologically Active Metabolites Synthesized by Microalgae
de Morais, M. G., Vaz, B. D. S., de Morais, E. G., & Costa, J. A. V. (2015) · BioMed Research International · doi:10.1155/2015/835761 · Cited by 470
Mori, T., O'Keefe, B. R., Sowder, R. C., Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J. A., Buckheit, R. W., McMahon, J. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411122200 · Cited by 445
Self-citationAntiviral potentials of medicinal plants
Mukhtar, M., Arshad, M., Ahmad, M., Pomerantz, R. J., Wigdahl, B., & Parveen, Z. (2008) · Virus Research · doi:10.1016/j.virusres.2007.09.008 · Cited by 429
Cyanobacteria: an emerging source for drug discovery
Singh, R. K., Tiwari, S. P., Rai, A. K., & Mohapatra, T. M. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.21 · Cited by 370
Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
De Clercq, E. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200009)20:5<323::aid-med1>3.0.co;2-a · Cited by 355
Top ten biotechnologies for improving health in developing countries
Daar, A. S., Thorsteinsdóttir, H., Martin, D. K., Smith, A. C., Nast, S., & Singer, P. A. (2002) · Nature Genetics · doi:10.1038/ng1002-229 · Cited by 352
Anti-HIV Activity of Extracts and Compounds from Algae and Cyanobacteria
Schaeffer, D. J., & Krylov, V. S. (2000) · Ecotoxicology and Environmental Safety · doi:10.1006/eesa.1999.1862 · Cited by 326
Natural Products from Cyanobacteria: Focus on Beneficial Activities
Demay, J., Bernard, C., Reinhardt, A., & Marie, B. (2019) · Marine Drugs · doi:10.3390/md17060320 · Cited by 324
Carbohydrate recognition by boronolectins, small molecules, and lectins
Jin, S., Cheng, Y., Reid, S., Li, M., & Wang, B. (2010) · Medicinal Research Reviews · doi:10.1002/med.20155 · Cited by 305
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
Balzarini, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1707 · Cited by 283
Cyanobactins—ribosomal cyclic peptides produced by cyanobacteria
Sivonen, K., Leikoski, N., Fewer, D. P., & Jokela, J. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2482-x · Cited by 275
Solution structure of cyanovirin-N, a potent HIV-inactivating protein
Bewley, C. A., Gustafson, K. R., Boyd, M. R., Covell, D. G., Bax, A., Clore, G. M., & Gronenborn, A. M. (1998) · Nature Structural Biology · doi:10.1038/828 · Cited by 265
Self-citationFungal LysM effectors: extinguishers of host immunity?
de Jonge, R., & Thomma, B. P. H. J. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2009.01.002 · Cited by 256
Bioactive compounds from microalgae: Current development and prospects
Fu, W., Nelson, D. R., Yi, Z., Xu, M., Khraiwesh, B., Jijakli, K., Chaiboonchoe, A., Alzahmi, A., Al-Khairy, D., Brynjolfsson, S., et al. (2017) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63929-5.00006-1 · Cited by 121
Antiviral Cyanometabolites—A Review
Mazur-Marzec, H., Cegłowska, M., Konkel, R., & Pyrć, K. (2021) · Biomolecules · doi:10.3390/biom11030474 · Cited by 64
PEGylation of cyanovirin–N, an entry inhibitor of HIV
Zappe, H., Snell, M. E., & Bossard, M. J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.016 · Cited by 57
Cyanotherapeutics: An emerging field for future drug discovery
Tiwari, A. K., & Tiwari, B. S. (2020) · Applied Phycology · doi:10.1080/26388081.2020.1744480 · Cited by 49
Lotfi, H., Sheervalilou, R., & Zarghami, N. (2017) · BioImpacts · doi:10.15171/bi.2018.16 · Cited by 30
Dhandayuthapani, K., Malathy, S., Mulla, S. I., & Gupta, S. K. (2021) · Algae · doi:10.1007/978-981-15-7518-1_7 · Cited by 19
Metadata
- Authors
- Boyd, M. R., Gustafson, K. R., McMahon, J. B., Shoemaker, R. H., O'Keefe, B. R., Mori, T., Gulakowski, R. J., Wu, L., Rivera, M. I., Laurencot, C. M., Currens, M. J., Cardellina, J. H., Buckheit, R. W., Nara, P. L., Pannell, L. K., Sowder, R. C., & Henderson, L. E.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1997-07
- Volume
- 41
- Issue
- 7
- Pages
- 1521-1530
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2138802639
- Cited by
- 605
- References
- 44
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.